ACCELERO partners with growing healthcare companies to explore, plan & execute business and financial strategies for successful product commercialization.
By intertwining the traditional consultancy with the expertise of independent specialists, this model makes us the choice for our clients.
If this is what you are looking for, then we are the right partner for you
Our service offers strategic advisory, attract investors and obtain funding, identify the right commercial partner, take your product to the next development phase and to build & grow a sustainable portfolio.
As the foundation for a successful venture we enable our clients in making informed strategic choices, define the principles and lay out the business and financial model to achieve long-term goals.
We dovetail for cooperation's or with in-house business development teams to help find, evaluate and assess new opportunities based on our comprehensive scouting platform.
CAPITAL RAISE ADVISORY
We connect our clients with potential investors or act on clients behalf. Over half of our growth capital raising engagements involve financing amounts over $15 million.
We are backing business angels and venture investors by doing strategic and risk/return assessments and valuation of growth companies to invest in.
POST FUNDING ADVISORY
By working continuously with the board and management team, we support newly funded companies and investors to maintain and succeed on the agreed strategic course.
Each of our partners has an advanced degree in their field, and at least 10 years of experience of working in that field. This combination of theoretical and practical understanding is critical for our strategic approach. Combined, our consultants have over 100 years of hands-on problem-solving expertise behind them, always with the end goal of our partner in mind.
That`s a lot of problems and even more solutions.
Dr. H. Joachim Kamps
Market Access &
Dr. Beat Widler
Clinical Research & Regulatory Affairs
Technical Operations &
Dr. Peter Schiemann
R&D Strategy Consulting
Dr. Barbara Troup
Strategic & Organizational Development
Dr. Peter Stangier
Company & Product Valuation
Founder & Managing Director
CEO at MEDODERM
European Head at ALEXION Pharma
Global Life Cycle Leader Haematology Franchise at Hoffman La Roche
Oncology, Haematology, Infectious Diseases, Autoimmune, Age-related Diseases & Rare Diseases
Global commercial, development and executive leadership expertise from a more than 20 year career in the pharmaceutical, biopharmaceutical and medical device industry.